Injection/Infusion
SOLIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/30ML
Summary
SOLIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/30ML — Injection/Infusion containing eculizumab. Hong Kong Registration No. HK-61188. Certificate Holder: ASTRAZENECA HONG KONG LIMITED. Date of Registration: 02 Apr, 2012.
Product NameSOLIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/30ML
Registration No.HK-61188
Certificate HolderASTRAZENECA HONG KONG LIMITED
Holder AddressUNIT 1-3, 11/F, CHINA TAIPING FINANCE CENTRE, 18 KING WAH RD, NORTH POINT, HONG KONG
Ingredientseculizumab
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration02 Apr, 2012
ATC codesL04AJ01
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL04
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。